Clinical Study of Visibility Tinted Clariti Contact Lens

NACompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

July 31, 2013

Study Completion Date

September 30, 2013

Conditions
HyperopiaMyopia
Interventions
DEVICE

Air Optix Aqua

Lenses will be worn on a daily wear basis (i.e. removed at night and stored in solution) and worn in the normal way. Lenses will be worn for one month. Lenses should be worn for a minimum of six hours a day, four days a week. The lenses are also to be worn for a minimum of two hours before attending all follow-up visits.

DEVICE

Clariti with Handling Tint

Lenses will be worn on a daily wear basis (i.e. removed at night and stored in solution) and worn in the normal way. Lenses will be worn for one month. Lenses should be worn for a minimum of six hours a day, four days a week. The lenses are also to be worn for a minimum of two hours before attending all follow-up visits.

Trial Locations (1)

M60 1QD

Eurolens Research Faculty of Life Sciences The University of Manchester, Manchester

All Listed Sponsors
lead

Sauflon Pharmaceuticals Ltd

INDUSTRY

NCT01996787 - Clinical Study of Visibility Tinted Clariti Contact Lens | Biotech Hunter | Biotech Hunter